...
首页> 外文期刊>Analytical Chemistry >PICquant: A Quantitative Platform To Measure Differential Peptide Abundance Using Dual-Isotopic Labeling with 12C6- and 13C6-Phenyl Isocyanate
【24h】

PICquant: A Quantitative Platform To Measure Differential Peptide Abundance Using Dual-Isotopic Labeling with 12C6- and 13C6-Phenyl Isocyanate

机译:PICquant:使用双同位素标记(具有12C6-和13C6-苯基异氰酸酯)的双同位素标记来测量差异肽丰度的定量平台

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

ABSTRACT: We have developed a complete system for thenisotopic labeling, fractionation, and automated quantificationnof differentially expressed peptides that significantly facilitatesncandidate biomarker discovery.We describe a new stablemassntagging reagent pair,n12nC6- and 13nC6-phenyl isocyanate (PIC),nthat offers significant advantages over currently available tags.nPeptides are labeled predominantly at their amino termini andnexhibit elution profiles that are independent of label isotope.nImportantly, PIC-labeled peptides have unique neutral-massnlosses upon CID fragmentation that enable charge state andnlabel isotope identification and, thereby, decouple the sequence identification from the quantification of candidate biomarkers. Tonexploit these properties, we have coupled peptide fractionation protocols with a Thermo LTQ-XL LC-MS2ndata acquisition strategynand a suite of automated spectrum analysis software that identifies quantitative differences between labeled samples. This approach,ndubbed the PICquant platform, is independent of protein sequence identification and excludes unlabeled peptides that otherwisenconfound biomarker discovery. Application of the PICquant platform to a set of complex clinical samples showed that the systemnallows rapid identification of peptides that are differentially expressed between control and patient groups.
机译:摘要:我们已经开发出了一套完整的系统,用于同位素标记,分级分离和自动定量检测差异表达的肽,可显着促进候选生物标志物的发现。我们描述了一种新的稳定的标记试剂对,n12nC6-和13nC6-苯基异氰酸酯(PIC),这具有明显的优势n肽主要在其氨基末端被标记,并且洗脱抑制谱独立于标记同位素。n重要的是,PIC标记的肽在CID裂解后具有独特的中性质失,从而能够实现电荷状态和n标记同位素的鉴定,从而解偶联序列从候选生物标志物的定量鉴定。为了充分发挥这些特性,我们将肽段分离方案与Thermo LTQ-XL LC-MS2ndata采集策略以及一套自动光谱分析软件相结合,可识别标记样品之间的定量差异。该方法被称为PICquant平台,与蛋白质序列鉴定无关,并且排除了否则会混淆生物标记物发现的未标记肽。将PICquant平台应用于一组复杂的临床样本表明,该系统允许快速识别在对照组和患者组之间差异表达的肽。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号